Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass Pharma both headed to the Nasdaq this ...

SpyGlass Pharma Inc. shares jumped 65% in the biopharmaceutical firm’s trading debut after it raised $150 million in an ...

Rickie Fowler already has two top-20 finishes this season and heads into Pebble Beach weekend with shot at title ...

Agomab Therapeutics and SpyGlass Pharma secured a combined $350 million in two separate initial public offerings on Thursday ...

A privately held ophthalmic company headquartered in Southern California (Aliso Viejo). The company’s development work is focused on glaucoma and related chronic eye conditions, with clinical studies ...

The new release reflects a growing demand for enterprise AI approaches that prioritize strong data foundations, ...

The companies filed a lawsuit against a special effects studio, which has threatened to initiate litigation over rights to ...

Jefferies, Leerink Partners, Citigroup and Stifel are acting as joint book-running managers for the offering.

Lionsgate has taken a 20% stake in Spyglass Media, and the companies together have formed a strategic content partnership. Lionsgate has also acquired most of the studio’s 200-film library, which ...